Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefixime (200mg) + Ornidazole (500mg) Tablet
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cefzlan O 500 Tablet containing Cefixime and Ornidazole is used for the management of mixed bacterial and protozoal infections. It helps control infection-causing organisms and supports effective recovery.
Cefixime works as a third-generation cephalosporin antibiotic, while Ornidazole acts against protozoal and anaerobic infections. Together, they provide broad-spectrum anti-infective coverage.
The tablet is widely prescribed in gastrointestinal infections, dental infections, gynecological infections, and other mixed infection conditions, leading to consistent prescription demand.
With increasing prevalence of mixed infections and growing demand for combination therapies, this product offers strong business potential for retailers and distributors. Its dual-action formulation, broad clinical relevance, and steady market demand make it a reliable product for growth in the anti-infective segment.
Some patients may experience nausea, vomiting, abdominal pain, metallic taste, headache, dizziness, or diarrhea. Rarely, allergic reactions, neurological effects such as dizziness or seizures, or liver function abnormalities may occur and require medical attention.
Cefzlan O 500 Tablet is indicated for gastrointestinal infections, infectious diarrhea, dysentery, typhoid fever, mixed bacterial-protozoal infections, and other abdominal infections caused by susceptible organisms. It helps control infection, reduce inflammation, and improve gastrointestinal symptoms.
This medicine should be used strictly under medical supervision. Avoid alcohol consumption during treatment and for at least 48 hours after completion due to the risk of severe reactions with Ornidazole. Complete the full prescribed course to prevent resistance and recurrence of infection.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Cefixime (200mg) + Sulbactam (150mg)
Composition : Cefixime (400mg)
Composition : Cefpodoxime Proxetil (100mg)
Composition : Cefpodoxime Proxetil (200mg)
Composition : Cefpodoxime Proxetil (200mg) + Clavulanic Acid (125mg)
Composition : Cefpodoxime Proxetil (200mg) + Ofloxacin (200mg)
Composition : Cefuroxime (250mg)
Composition : Cefuroxime (500mg)
Composition : Cefuroxime (500mg) + Clavulanic Acid (125mg)
Composition : Cephalexin (125mg) DT
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cefixime 200mg + Ornidazole 500mg Tablet has strong demand in the anti-infective, gastrointestinal, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on broad-spectrum infection management portfolios.
Medical distributors and agencies can benefit from consistent demand for mixed bacterial and protozoal infections under medical supervision. Cefixime 200mg is a third-generation cephalosporin antibiotic effective against a wide range of bacterial infections Ornidazole 500mg is an antiprotozoal and anaerobic antibacterial agent Commonly prescribed for diarrhea, dysentery, gastrointestinal infections, abdominal infections, and mixed bacterial-protozoal infections Provides broad coverage for both aerobic and anaerobic organisms Widely used by general physicians and gastroenterologists This strengthens a comprehensive anti-infective and gastrointestinal care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cefixime 200mg + Ornidazole 500mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong demand in general medicine practice, gastrointestinal infections, repeat prescriptions, reliable supply chain support, and attractive margins in the anti-infective segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.